We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPSN:SIXSwiss Prime Site AG Analysis

Data as of 2026-05-18 - not real-time

CHF 129.90

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Swiss Prime Site (SPSN) is trading at CHF 129.9, just above the computed support level of CHF 128 and below the 20‑day SMA of CHF 133.4, indicating a near‑term price floor. The RSI of 35 suggests the stock is oversold, while the MACD remains bearish, pointing to limited upside momentum in the short run. Valuation metrics show a PE of 27.2 versus an industry average of 31.9, and a price‑to‑book of 1.47, implying the stock is modestly undervalued relative to peers. Dividend yield of 2.71% and a payout ratio near 72% provide attractive income, but the high debt‑to‑equity ratio of 83% and total debt of CHF 5.87 bn raise leverage concerns. Despite a revenue decline of 19.6%, the company maintains strong margins (gross 88.7%, operating 75.5%) and generates solid free cash flow of CHF 318 m. Liquidity appears adequate with stable volume, though average volumes exceed recent trading activity, suggesting moderate liquidity risk. The beta is low (≈0.47), and 30‑day volatility sits at 14%, indicating a relatively stable price profile. Overall, the stock offers a blend of value and income with modest upside potential (≈2.5% upside/downside) but is constrained by leverage and stagnant growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support
  • Oversold RSI indicating potential rebound
  • Bearish MACD limiting immediate upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued relative to industry PE
  • Attractive dividend yield with sustainable cash flow
  • High leverage requiring monitoring

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Stable Swiss real‑estate market
  • Consistent high margins and free cash flow
  • Low beta and modest volatility supporting income focus

Key Metrics & Analysis

Financial Health

Revenue Growth-19.60%
Profit Margin68.31%
P/E Ratio27.2
ROE5.56%
ROA1.81%
Debt/Equity83.04
P/B Ratio1.5
Op. Cash FlowCHF354.7M
Free Cash FlowCHF318.3M
Industry P/E31.9

Technical Analysis

TrendNeutral
RSI35.4
SupportCHF 128.00
ResistanceCHF 138.00
MA 20CHF 133.43
MA 50CHF 136.33
MA 200CHF 123.47
MACDBearish
VolumeStable
Fear & Greed Index88.7

Valuation

Target PriceCHF 133.14
Upside/Downside2.50%
GradeUndervalued
TypeValue
Dividend Yield2.71%

Risk Assessment

Beta0.01
Volatility14.02%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.